Vir Biotechnology (VIR) Change in Account Payables (2018 - 2026)

Vir Biotechnology recorded quarterly Change in Account Payables of -$4.2 million in Q1 2026, down 243.01% quarter-over-quarter from $3.0 million in Q4 2025, and down 198.66% year-over-year from $4.3 million in Q1 2025.

Vir Biotechnology's Change in Account Payables history runs 9 years deep, the most recent figure standing at -$4.2 million for Q1 2026.

  • In Q1 2026, Change in Account Payables fell 198.66% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 169.66% YoY), while the FY2025 annual figure was $5.0 million, up 605.77% from the prior year.
  • Change in Account Payables came in at -$4.2 million for Q1 2026 at Vir Biotechnology, down from $3.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $8.9 million in Q2 2025 to a low of -$7.5 million in Q3 2023.
  • A 5-year average of $77176.5 and a median of -$934000.0 in 2023 frame the typical range for Change in Account Payables.
  • On a YoY basis, Change in Account Payables climbed as much as 406.22% in 2025 and fell as far as 292.52% in 2025.
  • Vir Biotechnology's Change in Account Payables stood at $2.8 million in 2022, then decreased by 6.18% to $2.6 million in 2023, then tumbled by 173.7% to -$1.9 million in 2024, then soared by 252.63% to $3.0 million in 2025, then plunged by 243.01% to -$4.2 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$4.2 million, $3.0 million, and -$5.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -3.26 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 35.60 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Vir Biotechnology 1.33 Bn 1.33 Bn - -4.23 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.23 Mn
Mar 31, 2026 -4.23 Mn
Dec 31, 2025 2.96 Mn
Dec 31, 2025 2.96 Mn
Sep 30, 2025 -5.40 Mn
Sep 30, 2025 -5.40 Mn
Jun 30, 2025 8.86 Mn
Jun 30, 2025 8.86 Mn
Mar 31, 2025 -1.42 Mn
Mar 31, 2025 -1.42 Mn
Dec 31, 2024 -1.94 Mn
Dec 31, 2024 -1.94 Mn
Sep 30, 2024 3.11 Mn
Sep 30, 2024 3.11 Mn
Jun 30, 2024 -2.89 Mn
Jun 30, 2024 -2.89 Mn
Mar 31, 2024 735,000.00
Mar 31, 2024 735,000.00
Dec 31, 2023 2.63 Mn
Dec 31, 2023 2.63 Mn
Sep 30, 2023 -7.53 Mn
Sep 30, 2023 -7.53 Mn
Jun 30, 2023 -934,000.00
Jun 30, 2023 -934,000.00
Mar 31, 2023 6.56 Mn
Mar 31, 2023 6.56 Mn
Dec 31, 2022 2.80 Mn
Dec 31, 2022 2.80 Mn
Sep 30, 2022 -4.45 Mn
Sep 30, 2022 -4.45 Mn
Jun 30, 2022 -1.39 Mn
Jun 30, 2022 -1.39 Mn
Mar 31, 2022 3.83 Mn
Mar 31, 2022 3.83 Mn
Dec 31, 2021 788,000.00
Dec 31, 2021 788,000.00
Sep 30, 2021 -5.89 Mn
Sep 30, 2021 -5.89 Mn
Jun 30, 2021 6.25 Mn
Jun 30, 2021 6.25 Mn
Mar 31, 2021 -1.32 Mn
Mar 31, 2021 -1.32 Mn
Dec 31, 2020 -1.83 Mn
Dec 31, 2020 -1.83 Mn
Sep 30, 2020 2.38 Mn
Sep 30, 2020 2.38 Mn
Jun 30, 2020 -14.29 Mn
Jun 30, 2020 -14.29 Mn
Mar 31, 2020 12.94 Mn
Mar 31, 2020 12.94 Mn
Dec 31, 2019 536,000.00
Dec 31, 2019 536,000.00
Sep 30, 2019 1.26 Mn
Sep 30, 2019 1.26 Mn
Jun 30, 2019 -2.00 Mn
Jun 30, 2019 -2.00 Mn
Mar 31, 2019 1.16 Mn
Mar 31, 2019 1.16 Mn
Dec 31, 2018 -1.23 Mn
Dec 31, 2018 -1.23 Mn